Sign in
8-K/A

Current Report

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-20-011563

Material agreement · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading form8-ka.htm…